[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Wu et al., 1986 - Google Patents

Analysis of the DNA of hepatitis B virus in the sera of Chinese patients infected with hepatitis B

Wu et al., 1986

Document ID
9339189928402345583
Author
Wu J
Lee S
Wang J
Ting L
Tsai Y
Lo K
Chiang B
Tong M
Publication year
Publication venue
The Journal of infectious diseases

External Links

Snippet

Materials and Methods Patients. Serum samples from 204 consecutive patients (141 males and 63 females) with HBV-related liver diseases were tested under code, and results were classified accord-ing to their clinicopathologic findings and HBeAg status (table 1). There …
Continue reading at www.jstor.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis

Similar Documents

Publication Publication Date Title
Pignatelli et al. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection
Luo et al. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen
Brechot et al. Multiplication of hepatitis B virus in fulminant hepatitis B.
Ohkawa et al. Long‐term follow‐up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses
Borghesio et al. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon‐treated patients and in patients who underwent liver transplantation
Wu et al. Analysis of the DNA of hepatitis B virus in the sera of Chinese patients infected with hepatitis B
Moreno-Otero et al. Development of Cirrhosis after Chronic Type B Hepatitis: A Clinicopathologic and Follow--up Study of 46 HBeAg--Positive Asymptomatic Patients.
Honarkar et al. Occult hepatitis B among chronic liver disease patients
Shimizu et al. High prevalence of antibody to hepatitis C virus in heavy drinkers with chronic liver diseases in Japan
Chu et al. Correlation of age with the status of hepatitis B virus replication and histological changes in chronic type B hepatitis
Koike et al. IgM anti‐HBc in anti‐HBe positive chronic type B hepatitis with acute exacerbations
Yu et al. GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-α therapy
Tassopoulos et al. Search for hepatitis B virus DNA in sera from patients with acute type B or non-A, non-B hepatitis
Ferraz et al. Fulminant hepatitis in patients undergoing liver transplantation: Evidence for a non‐A, non‐B, non‐C, non‐D, and non‐E syndrome
Wu et al. Symptomatic anti‐HBe positive chronic hepatitis B in Taiwan with special reference to persistent HBV replication and HDV superinfection
Pao et al. Hepatitis type B virus DNA in patients receiving hemodialysis: correlation with other HBV serological markers
Shamma'a Acute viral hepatitis in Lebanon: evidence for an HAV‐like non‐A non‐B hepatitis
Colloredo et al. Semiquantitative assessment of IgM antibody to hepatitis B core antigen and prediction of the severity of chronic hepatitis B
Shev et al. GBV‐C/HGV infection in hepatitis C virus‐infected deferred Swedish blood donors
Dusheiko et al. Hepatitis B core and surface antigen expression in HBeAg and HBV DNA positive chronic hepatitis B: correlation with clinical and histological parameters
Shindo et al. Elevated levels of 2′, 5′‐oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B
WANG et al. Delta hepatitis virus infection in China
KAWANO et al. Clinical usefulness of an assay for hepatitis C virus core in the diagnosis of non‐A, non‐B hepatitis and monitoring of the response to interferon therapy
Chu et al. Diagnosis of acute type B hepatitis by a solid phase u‐antibody capture radioimmunoassay for IgM class antibody to hepatitis B core antigen: a diagnostic proposal based on a prospective study
Löfgren et al. Evaluation of a new radioimmunoassay for detecting hepatitis B e antigen and its antibody